ESR2 and malignant colon neoplasm: Increases the expression of ERβ and reduces the expression of ERα, insulin‐like growth factor receptor (IGF‐1R), and p‐Akt. Also causes down‐regulation of miR‐95 to increase the apoptosis of colon cancer cells.